Agis H, Füreder W, Bankl HC, et al. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 1996;87:535-43.

Akin C & Metcalfe DD. The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 2004;114:13-9.

Alexandrakis MG, Kyriakou DS, Seretakis D, et al. Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1). Int J Immunopathol Pharmacol 2003;16:43-47.

Ashman LK. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 1999;31:1037-51.

Babina M, Guhl S, Stärke A, Kirchhof L, Zuberbier T & Henz BM. Comparative cytokine profile of human skin mast cells from two compartments - strong resemblance with monocytes at baseline, but induction of IL-5 by IL-4 priming. J Leukoc Biol 2004;75:244-52.

Babina M & Henz BM. All-trans retinoic acid down-regulates expression and function of β 2 integrins by human monocytes: opposite effects on monocytic cell lines. Eur J Immunol 2003;33:616-25.

Babina M, Mammeri K & Henz BM. Retinoic acid up-regulates myeloid ICAM-3 expression and function in a cell-specific fashion – evidence for retinoid signaling pathways in the mast cell lineage. J Leukoc Biol 2001;69:361-72.

Babina M, Schulke Y, Kirchhof L, et al. The transcription factor profile of human mast cells in comparison with monocytes and granulocytes. Cell Mol Life Sci 2005a;62:214-26.

Babina M, Thienemann F, Guhl S, et al. All-trans retinoic Acid is dedifferentiating to human maszcells. Brit J Haemtol 2005b. Zur Publikation eingereicht.

Babina M, Weber S & Henz BM. CD43 (leukosialin, sialophorin) expression is differentially regulated by retinoic acids. Eur J Immunol 1997a;27:1147-51.

Babina M, Weber S & Henz BM. Retinoic acids and dexamethasone alter cell-surface density of β 2-integrins and ICAM-1 on human leukemic (HMC-1) mast cells. Arch Dermatol Res 1997b;289:111-15.

Balmer JE & Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 2002;43:1773-808.

Barnes JA, Singh S & Gomes AV. Protease activated receptors in cardiovascular function and disease. Mol Cell Biochem 2004;263:227-39.

Beil WJ, Schulz M & Wefelmeyer U. Mast cell granule composition and tissue location--a close correlation. Histol Histopathol 2000;15 :937-46.

Benthin M, Dallmann I & Atzpodien J. 13cis- and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatment in vitro. Cancer Biother Radiopharm 2001;16:323-31.

Berg JM, Tymoczko JL, Stryer L, eds. Biochemistry. 5th ed. International Version. New York, USA : Freeman W , 2002 .

Besmer P, Murphy JE, George PC, et al. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 1986;320:415-21.

Bhattacharyya SN, Manna B, Ashbaugh P, Coutinho R & Kaufman B. Differentiation of respiratory epithelium: the effects of retinoic acid and carcinogens on the expression of mucociliary vs. squamous phenotype. Inflammation 1997;21:133-43.

Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R & Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 1999;96:8080-85.

Blank U, Ra C, Miller L, White K, Metzger H & Kinet JP. Complete structure and expression in transfected cells of high affinity IgE receptor. Nature 1989;337:187-9.

Breitman TR, Collins SJ & Keene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981;57:1000-4.

Breitman TR, Selonick, SE & Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980;77:2936-40.

Brizzi MF, Pavan M, Zini MG, Avanzi GC & Pegoraro L. Regulation of c-kit expression in human myeloid cells. Stem Cells 1993;11:42-48.

Butterfield JH, Weiler D, Dewald G & Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988;12:345-55.

Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996;10:940-54.

Chatila TA. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med 2004;10:493-9.

Chomienne C, Fenaux P & Degos L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J 1996;10:1025-30.

Church MK & Clough GF. Human skin mast cells: in vitro and in vivo studies. Ann Allergy Asthma Immunol 1999;83:471-5.

Coelho AM, Ossovskaya V & Bunnett NW. Proteinase-activated receptor-2: physiological and pathophysiological roles. Curr Med Chem Cardiovasc Hematol Agents 2003;1:61-72.

Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 2002;16:1896-905.

Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996;183:2681-6.

Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ & Fang KC. Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. J Biol Chem 2004;279:5612-20.

Czarnetzki BM, Grabbe J, Kolde G, Kruger-Krasagakes S, Welker P & Zuberbier T. Mast cells in the cytokine network: the what, where from and what for. Exp Dermatol 1995;4: 221-6.

Dawson MI. Synthetic retinoids and their nuclear receptors. Curr Med Chem Anti-Canc Agents 2004;4:199-230.

De Luca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 1991;5:2924-33.

Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K & Oberg F. Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27Kip1. Blood 2002;99:2199-206.

Doggrell SA & Wanstall JC. Vascular chymase: pathophysiological role and therapeutic potential of inhibition. Cardiovasc Res 2004;61:653-62.

Dolle L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V & Hondermarck H. Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets 2004;4:463-70.

Dombrowicz D, Flamand V, Brigman KK, Koller BH & Kinet JP. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α -chain gene. Cell 1993;75:969-76.

Douer D, Ramezani L, Parker J & Levine AM. All-trans-retinoic acid effects the growth, differentiation and apoptosis of normal myeloid progenitors derived from purified CD34+ bone marrow cells. Leukemia 2000;14:874-81.

Ehrlich P. Beiträge zur Kenntnis der granulierten Bindegewebszellen und der eosinophilen Leukozyten. Arch Anat Physiol 1879;3:166-69.

Enerback L. Mucosal mast cells in the rat and in man. Int Arch Allergy Appl Immunol 1987;82:249-55.

Fenaux P, Chomienne C & Degos L. Treatment of acute promyelocytic leukaemia. Best Pract Res Clin Haematol 2001;14:153-74.

Forsythe P & Ennis M. Clinical consequences of mast cell heterogeneity. Inflamm Res 2000;49:147-54.

Fritsch P & Vanscheidt W. Flowzytometrie in der Dermatologie. Hautarzt 1996;47:561-78.

Frossard N, Freund V & Advenier C. Nerve growth factor and its receptors in asthma and inflammation. Eur J Pharmacol 2004;500:453-65.

Fung-Leung WP, Thurmond RL, Ling P & Karlsson L. Histamine H4 receptor antagonists: the new antihistamines? Curr Opin Investig Drugs. 2004;5:1174-83.

Furitsu T, Tsujimura T, Tono T, et al. Identification of mutations in the coding region of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993;92:1736-44.

Galli SJ, Maurer M & Lantz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999;11:53-59.

Galli SJ & Wershil BK. The two faces of the mast cell. Nature 1996;381:21-2.

Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T & Heinrich PC. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988;18:717-21.

Goli M & Brown S. HPLC method for quantification of 13-cis retinoic acid (13-cis ra) subjected to light and heat treatments. Mississippi Academy of Sciences (MAS). (Accessed April 20, 2005, at

Gollnick HP & Krautheim A. Topical treatment in acne: current status and future aspects. Dermatology 2003;206:29-36.

Grabbe J, Welker P, Dippel E & Czarnetzki BM. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994;287:78-84.

Groneberg DA, Serowka F, Peckenschneider N, et al. Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 2005;161:87-92.

Grutzkau A, Kruger-Krasagakes S, Baumeister H, et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998 ;9:875-84.

Gudas LJ, Sporn MB & Roberts AB. Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts BS, Goodman DS, eds. The retinoids: biology, chemistry, and medicine. New York, USA: Raven Press, 1994:443-520.

Guhl S, Hartmann K, Tapkenhinrichs S, et al. Ultraviolet irradiation induces apoptosis in human immature, but not in skin mast cells. J Invest Dermatol 2003;121:837-44.

Hakimi J, Seals C, Kondas J, Pettine L, Danho W & Kochan J. The α subunit of the human IgE receptor (Fc ε RI) is sufficient for high affinity IgE binding. J Biol Chem 1990;265:22079-81.

Hamann K, Grabbe J, Welker P, Haas N, Algermissen B & Czarnetzki BM. Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res 1994;286:380-5.

Harris P & Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol 1985;37:407-22.

Hart PH, Bonder CS, Balogh J, Dickensheets HL, Donnelly RP & Finlay-Jones JJ. Differential responses of human monocytes and macrophages to IL-4 and IL-13. J Leukoc Biol 1999;66:575-8.

Hasegawa S, Pawankar R, Suzuki K, et al. Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its' intracellular expression in human megakaryocytes. Blood 1999;93:2543-51.

Hayashi S, Kunisada T, Ogawa M & Nishikawa S. Identification of the control regions for mouse c-kit gene transcription induced by retinoic acid. DNA Res 1995;2:211-18.

Heinrich MC & Corless CL. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy. J Surg Oncol 2005;90:195-207.

Henz BM, Maurer M, Lippert U, Worm M & Babina M. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001;10:1-10.

Herault O, Domenech J, Degenne M, et al. All-trans-retinoic acid up-regulates CD38 but not c-Kit antigens on human marrow CD34+ cells without recruitment into cell cycle. Br J Haematol 1998;103:343-50.

Hjertson M, Kivinen PK, Dimberg L, Nilsson K, Harvima IT & Nilsson G. Retinoic acid inhibits in vitro development of mast cells but has no marked effect on mature human skin tryptase- and chymase-positive mast cells. J Invest Dermatol 2003;120:239-45.

Holgate ST, Church MK & Kapp A. Allergologie. München: Urban & Fischer, 1996.

Humphries DE, Wong GW, Friend DS, et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999;400:769-72.

Huntley JF. Mast cells and basophils: a review of their heterogeneity and function. J Comp Pathol 1992;107:349-72.

Irani AM, Nilsson G, Miettinen U, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992;80:3009-21.

Irani AM & Schwartz LB. Human mast cell heterogeneity. Allergy Proc 1994;15:303-8.

Ishida S, Kinoshita T, Sugawara N, Yamashita T & Koike K. Serum inhibitors for human mast cell growth: possible role of retinol. Allergy 2003;58:1044-52.

Iwakiri R, Inokuchi K, Dan K & Nomura T. Marked basophilia in acute promyelocytic leukaemia treated with all-trans retinoic acid: molecular analysis of the cell origin of the basophils. Br J Haematol 1994;86:870-72.

Jablonowski JA, Carruthers NI & Thurmond RL. The histamine H4 receptor and potential therapeutic uses for H4 ligands. Mini Rev Med Chem 2004 ;4:993-1000.

James SY, Williams MA, Kelsey SM, Newland AC & Colston KW. The role of vitamin D derivatives and retinoids in the differentiation of human leukaemia cells. Biochem Pharmacol 1997;54:625-34.

Jensen BM, Dissing S, Skov PS & Poulsen LK. A Comparative Study of the Fc ε RI Molecule on Human Mast Cell and Basophil Cell Lines. Int Arch Allergy Immunol 2005;137:93-103.

Jutel M, Watanabe T, Akdis M, Blaser K & Akdis CA. Immune regulation by histamine. Curr Opin Immunol 2002; 14: 735-40.

Kallen KJ, Galle PR & Rose-John S. New developments in IL-6 dependent biology and therapy: where do we stand and what are the options? Expert Opin Investig Drugs 1999;8:1327-49.

Kambe M, Kambe N, Oskeritzian CA, Schechter N & Schwartz LB. IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells. Clin Exp Allergy 2001 ; 31 :1077-85.

Kambhampati S, Verma A, Li Y, Parmar S, Sassano A & Platanias LC. Signalling pathways activated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Leuk Lymphoma 2004;45 :2175-85.

Kanbe N, Kurosawa M, Miyachi Y, Kanbe M, Saitoh H & Matsuda H. Nerve growth factor prevents apoptosis of cord blood-derived human cultured mast cells synergistically with stem cell factor. Clin Exp Allergy 2000;30:1113-20.

Kastner P, Mark M & Chambon P. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell 1995;83:859-69.

Kinet JP. The high-affinity IgE receptor (Fc ε RI): from physiology to pathology. Ann Rev Immunol 1999;17:931-72.

Kinoshita T, Koike K, Mwamtemi HH, et al. Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors. Blood 2000;95:2821-28.

Kinoshita T, Sawai N, Hidaka E, Yamashita T & Koike K. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells. Blood 1999;94:496-508.

Kirshenbaum AS, Akin C, Wu Y, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of Fc ε RI or Fc γ RI. Leukemia Res 2003;27:677-82.

Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM & Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13). Blood 1999;94:2333-42.

Kitamura Y, Go S & Hatanaka S. Decrease of mast cells in W/W V mice and their increase by bone marrow transplantation. Blood 1978;52:447-52.

Kitamura Y & Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci 2004;61:2924-31.

Kitamura Y, Kasugai T, Arizono N & Matsuda H. Development of mast cells and basophils: processes and regulation mechanisms. Am J Med Sci 1993;306:185-91.

Klinke R & Silbernagl S. Lehrbuch der Physiologie. Stuttgart: Thieme Verlag Stuttgart, 2003.

Kreutz M, Fritsche J, Ackermann U, Krause SW & Andreesen R. Retinoic acid inhibits monocyte to macrophage survival and differentiation. Blood 1998;91:4796-802.

Kruger-Krasagakes S, Moller A, Kolde G, Lippert U, Weber M & Henz BM. Production of interleukin-6 by human mast cells and basophilic cells. Invest Dermatol 1996;106:75-9.

Lad SP, Neet KE & Mufson EJ. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 2003;2:315-34.

Lambiase A, Micera A, Sgrulletta R, Bonini S & Bonini S. Nerve growth factor and the immune system: old and new concepts in the cross-talk between immune and resident cells during pathophysiological conditions. Curr Opin Allergy Clin Immunol 2004;4:425-30.

Lawson ND & Berliner N. Neutrophil maturation and the role of retinoic acid. Exp Hematol 1999;27:1355-67.

Lora JM, Al-Garawi A, Pickard MD, et al. Fc ε RI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines. J Allergy Clin Immunol 2003;112:1119-126.

Lorentz A & Bischoff SC. Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol Rev 2001;179:57-60.

Lorentz A, Schwengberg S, Sellge G, Manns MP & Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol 2000;164:43-48.

Lorigados-Pedre L & Bergado-Rosado J. Nerve growth factor in neurodegeneration and neurorestorative therapy. Rev Neurol 2004;38:957-71.

Maden M & Hind M. Retinoic acid in alveolar development, maintenance and regeneration. Philos Trans R Soc Lond B Biol Sci 2004;359:799-808.

Maden M. The role of retinoic acid in embryonic and post-embryonic development. Proc Nutr Soc 2000;59:65-73.

Malaviya R & Georges A. Regulation of mast cell-mediated innate immunity during early response to bacterial infection. Clin Rev Allergy Immunol 2002;22:189-204.

Mangelsdorf DJ, Borgmeyer U, Heyman RA, et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992;6:329-44.

Mangelsdorf DJ, Ong ES, Dyck JA & Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990;345:224-9.

Matikainen S & Hurme M. Comparison of retinoic acid and phorbol myristate acetate as inducers of monocytic differentiation. Int J Cancer 1994;57:98-103.

Maurer M, Theoharides T, Granstein RD, et al. What is the physiological function of mast cells? Exp Dermatol 2003;12:886-910.

Maurer M, Wedemeyer J, Metz M, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004;432:512-6.

Metcalfe DD, Baram D & Mekori YA. Mast cells. Physiol Rev 1997;77:1033-79.

Mitsui H, Furitsu T, Dvorak AM, et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A 1993;90:735-9.

Moya-Garcia AA, Medina MA & Sanchez-Jimenez F. Mammalian histidine decarboxylase: from structure to function. Bioessays 2005;27:57-63.

Mueller TD, Zhang JL, Sebald W & Duschl A. Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim Biophys Acta 2002;1592:237-50.

Nagpal S & Chandraratna RA. Vitamin A and regulation of gene expression. Curr Opin Clin Nutr Metab Care 1998;1:341-6.

Nakahata T, Tsuji K, Tanaka R, et al. Synergy of stem cell factor and other cytokines in mast cell development. In: Kitamura Y, Yamamoto S, Galli SJ, eds. Biological and Molecular Aspects of Mast Cell and Basophil Differentitation and Function. New York, USA: Raven Press, 1995:13-24.

Nilsson G, Blom T, Kusche-Gullberg M, et al. Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 1994a;39:489-98.

Nilsson G, Miettinen U, Ishizaka T, Ashman LK, Irani AM & Schwartz LB. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 1994b;84:1519-27.

Nilsson G & Nilsson K. Effects of interleukin (IL)-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL-4. Eur J Immunol 1995;25:870-73.

Nishimoto N & Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004;4:386-91.

Nwankwo JO. Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (+)-catechin in Dunning rat invasive prostate adenocarcinoma cells. Anticancer Res 2002;22:4129-35.

Olsson IL & Breitman TR. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3’:5’-monophosphate-inducing agents. Cancer Res 1982;42:3924-27.

Oskeritzian CA, Wang Z, Kochan JP, et al. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J Immunol 1999;163:5105-15.

Otsuki T, Sakaguchi H, Hatayama T, Wu P, Takata A & Hyodoh F. Effects of all-trans retinoic acid (ATRA) on human myeloma cells. Leuk Lymphoma 2003;44:1651-6.

Payne V & Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004;59:695-703.

Petkovich M, Brand NJ, Krust A & Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987;330:444-50.

Petkovich PM. Retinoic acid metabolism. J Am Acad Dermatol 2001;45:136-42.

Petruska JC & Mendell LM. The many functions of nerve growth factor: multiple actions on nociceptors. Neurosci Lett 2004;361:168-71.

Piao YF, Shi Y & Gao PJ. Inhibitory effect of all-trans retinoic acid on human hepatocellular carcinoma cell proliferation. World J Gastroenterol 2003;9:2117-20.

Pittenger G & Vinik A. Nerve growth factor and diabetic neuropathy. Exp Diabesity Res 2003;4:271-85.

Purton LE, Bernstein ID & Collins SJ. All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1+) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 1999;94:483-95.

Purton LE, Bernstein ID & Collins SJ. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 2000;95:470-77.

Reed CE & Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004;114:997-1008.

Ronnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci 2004;61 :2535-48.

Rook GA, Hernandez-Pando R, Dheda K & Teng Seah G. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol 2004;25:483-8.

Rote Liste® Service GmbH. Roteliste 2005. Aulendorf: ECV Editio Cantor Verlag, 2005.

Ryan JJ, DeSimone S, Klisch G, et al. IL-4 inhibits mouse mast cell Fc ε RI expression through a STAT6-dependent mechanism. J Immunol 1998;161:6915-23.

Saatcioglu F, Claret FX & Karin M. Negative transcriptional regulation by nuclear receptors. Semin Cancer Biol 1994;5:347-59.

Saito H, Ebisawa M, Sakaguchi N, et al. Characterization of cord-blood-derived human mast cells cultured in the presence of Steel factor and interleukin-6. Int Arch Allergy Immunol 1995;107:63-5.

Sammons J, Ahmed NA, Khokher MA & Hassan HAT. Mechanisms mediating the inhibitory effect of all-trans retinoic acid on primitive hematopoietic stem cells in human long-term bone marrow. Stem Cells 2000;18:214-19.

Schechter NM, Brass LF, Lavker RM & Jensen PJ. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 1998;176:365-73.

Scheffold A & Kern F. Recent developments in flow cytometry. J Clin Immunol 2000;20:400-7.

Schoeler D, Grützkau A, Henz BM, Küchler J & Krüger-Krasagakis S. Interleukin-6 enhances whereas tumor necrosis factor alpha and interferons inhibit integrin expression and adhesion of human mast cells to extracellular matrix proteins. J Invest Dermatol 2003;120:795-801.

Scholl PR & Geha RS. Physical association between the highaffinity IgG receptor (Fc γ RI) and the γ subunit of the high-affinity IgE receptor (Fc ε RI γ ). Proc Natl Acad Sci USA 1993;90:8847-50.

Schwartz LB. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leukemia Res 2001;25:553-62.

Shimamoto Y, Suga K, Yamaguchi M, Kuriyama K & Tomonaga M. Prophylaxis of symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with all-trans retinoic acid. Acta Haematol 1994;92:109-12.

Shimizu Y, Ashman LK, Du Z & Schwartz LB. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit. J Immunol 1996;156:3443-9.

Shiohara M & Koike K. Regulation of mast cell development. Chem Immunol Allergy 2005;87:1-21.

Shore PA. The chemical determination of histamine. Methods Biochem Anal 1971;5:89-97.

Silbernagel S & Lang F. Taschenatlas der Physiologie. Stuttgart: Thieme Verlag, 1998.

Smith SJ, Ying S, Meng Q, et al. Blood eosinophils from atopic donors express messenger RNA for the alpha, beta, and gamma subunits of the high-affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein. J Allergy Clin Immunol 2000;105:309-17.

Smith W & Saba N. Retinoids as chemoprevention for head and neck cancer: where do we go from here? Crit Rev Oncol Hematol 2005;55:143-52.

Song L & Schindler C. IL-6 and the acute phase response in murine atherosclerosis. Atherosclerosis 2004;177:43-51.

Sonoda Y. Interleukin-4 - a dual regulatory factor in hematopoiesis. Leuk Lymphoma 1994;14:231-40.

Steinhoff M, Buddenkotte J, Shpacovitch V, et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 2005;26:1-43.

Steinke JW. Anti-interleukin-4 therapy. Immunol Allergy Clin North Am 2004;24:599-614.

Stryer L. Biochemie. 4.Auflage. Heidelberg: Spektrum Akademischer Verlag, 1996.

Thienemann F, Henz BM & Babina M. Regulation of mast cell characteristics by cytokines: divergent effects of interleukin-4 on immature mast cell lines versus mature human skin mast cells. Arch Dermatol Res 2004a;296:134-38.

Thienemann F, Guhl S, Rex C, et al. All-trans Retinoic Acid is Dedifferentiating to Human Mast Cells Independent of their Stage of Maturation. J Invest Dermatol 2004b;123:A6.

Torii I, Morikawa S, Harada T & Kitamura Y. Two distinct types of cellular mechanisms in the development of delayed hypersensitivity in mice: requirement of either mast cells or macrophages for elicitation of the response. Immunology 1993;78:482-90.

Toru H, Eguchi M, Matsumoto R, Yanagida M, Yata J & Nakahata T. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 1998;91:187-95.

Toru H, Ra C, Nonoyama S, Suzuki K, Yata J & Nakahata T. Induction of the high-affinity IgE receptor (Fc ε RI) on human mast cells by IL-4. Int Immunol 1996;8:1367-73.

Unger T & Li J. The role of the renin-angiotensin-aldosterone system in heart failure. J Renin Angiotensin Aldosterone Syst 2004;5:7-10.

Upham JW, Sehmi R, Hayes LM, Howie K, Lundahl J & Denburg JA. Retinoic acid modulates IL-5 receptor expression and selectively inhibits eosinophil-basophil differentiation of hemopoietic progenitor cells. J Allergy Clin Immunol 2002;109:307-13.

Valent P, Bevec D, Maurer D, et al. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci USA 1991;88:3339-42.

Valent P, Spanblochl E, Sperr WR, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992;80:2237-45.

Watanabe T & Ohtsu H. L-histidine decarboxylase as a probe in studies on histamine. Chem Rec 2002;2:369-76.

Watanabe T. Studies on histamine with L-histidine decarboxylase, a histamine-forming enzyme, as a probe: from purification to gene knockout. Nippon Yakurigaku Zasshi 2001;118:159-69.

Weber A, Knop J & Maurer M. Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol 2003;148:224-8.

Weber S, Babina M, Krüger-Krasagakes S, Grützkau A & Henz BM. A subclone (5C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line. Arch Dermatol Res 1996;288:778-82.

Weber S, Kruger-Krasagakes S, Grabbe J, Zuberbier T & Czarnetzki BM. Mast cells. Int J Dermatol 1995;34:1-10.

Welker P, Grabbe J, Gibbs B, Zuberbier T & Henz BM. Nerve growth factor- β induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology 2000;99:418-26.

Welker P, Grabbe J, Grutzkau A & Henz BM. Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 1998;94:310-7.

Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 1997;61:233-45.

Xia HZ, Du Z, Craig S, et al. Effect of recombinant human IL-4 on tryptase, chymase, and Fc ε receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J Immunol 1997;159:2911-21.

Yee NS, Langen H & Besmer P. Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells. J Biol Chem 1993;268:14189-201.

Yu VC, Delsert C, Andersen B, et al. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991;67:1251-66.

Zouboulis CC. Retinoids--which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol 2001;14:303-15.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: